8 New FDA-Approved Neurology Drugs

A look at the newest FDA-approved drugs for neurologic diseases, including Parkinson's disease and MS.

Recent Content

Efficacy of acute medication matters beyond just treating a single migraine. It may increase the risk of worsened disease.

These agents lower cholesterol and prevent cardiovascular disease, but they may actually increase the risk of Parkinson disease. Caution advised.

Minimally invasive surgery to remove clots from the brain and other cutting-edge stroke news for neurologists highlighted the research and clinical program at the International Stroke Conference.

The ultimate cause is found in only about half of patients, so improved understanding of the prognostic and diagnostic features is of high priority.

This treatment may be superior to current treatment for patients with severe multiple sclerosis that is not responding well to standard treatments.

Drugs often involve multiple daily doses with complex dosing regimens, but interventions that have been applied generically to patients with chronic diseases can be applied to these cases as well.

The FDA has recently approved a number of drugs for a variety of neurologic disorders, including Parkinson's disease and MS. Here are 8 of the newest.

By clicking Accept, you agree to become a member of the UBM Medica Community.